First United Kingdom Heart and Renal Protection (UK-HARP-I) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease-Reference-Cited by-同舟云学术

First United Kingdom Heart and Renal Protection (UK-HARP-I) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease

Published:2005-03 Issue:3 Volume:45 Page:473-484
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Baigent Colin,Landray Martin,Leaper Craig,Altmann Paul,Armitage Jane,Baxter Alex,Cairns Hugh S.,Collins Rory,Foley Robert N.,Frighi Valeria,Kourellias Karen,Ratcliffe Peter J.,Rogerson Mary,Scoble John E.,Tomson Charles R.V.,Wheeler David C.,Warwick Graham

Publisher

Elsevier BV

Subject

Nephrology

Reference27 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease;Lancet,1994

2. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels;N Engl J Med,1998

3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels;Sacks;N Engl J Med,1996

4. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals;Lancet,2002

5. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions;Lancet,2004

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of statin therapy in kidney transplant recipients: a systematic review and meta-analysis;Lipids in Health and Disease;2024-09-11

2. Pharmacotherapy for Coronary Artery Disease and Acute Coronary Syndrome in the Aging Population;Current Atherosclerosis Reports;2024-05-09

3. Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis;American Journal of Cardiovascular Drugs;2024-02-01

4. Special Populations;Clinical Lipidology;2024

5. Low‐dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real‐world nationwide cohort study;Journal of Diabetes Investigation;2023-12-21